MEDIZEN HUMANCARE Inc. (XKON:236340)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,679.00
-5.00 (-0.30%)
At close: Jun 13, 2025, 3:30 PM KST
-64.80%
Market Cap 3.69B
Revenue n/a
Net Income n/a
Shares Out 2.30M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 9,164
Average Volume 1,178
Open 1,800.00
Previous Close 1,684.00
Day's Range 1,432.00 - 1,935.00
52-Week Range 1,432.00 - 5,200.00
Beta 0.07
RSI 35.08
Earnings Date n/a

About MEDIZEN HUMANCARE

MEDIZEN HUMANCARE Inc., a research company, engages in the genomic analysis to predict diseases on an individual basis in Asia, the Americas, Europe, and internationally. Its services include M-CHECK, which provides an analysis of patients’ risk for genetic diseases using genomic variation packages related to specific diseases with gene chips or analysis kits; and MELTHY (DTC), a DNA analysis service. The company was founded in 2012 and is based in Seoul, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2012
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 236340
Full Company Profile

News

There is no news available yet.